Back to Search Start Over

The influence of perilipin 5 deficiency on gut microbiome profiles in murine metabolic dysfunction-associated fatty liver disease (MAFLD) and MAFLD-hepatocellular carcinoma.

Authors :
Krizanac M
Štancl P
Mass-Sanchez PB
Karlić R
Moeckel D
Lammers T
Asimakopoulos A
Weiskirchen R
Source :
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Oct 14; Vol. 14, pp. 1443654. Date of Electronic Publication: 2024 Oct 14 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as the leading cause of hepatocellular carcinoma (HCC) worldwide. Over the years, Perilipin 5 (PLIN5) has been recognized as a key regulator of both MAFLD and HCC development. In our previous studies we demonstrated that deficiency in Plin5 reduces the severity of MAFLD and HCC in mice. Interestingly, it has been established that patients with MAFLD and HCC exhibit various changes in their gut microbiome profiles. The gut microbiome itself has been shown to play a role in modulating carcinogenesis and the immune response against cancer.<br />Methods: Therefore, we conducted a study to investigate the alterations in fecal microbiome composition in wild type (WT) and Plin5 -deficient ( Plin5 <superscript>-/-</superscript> ) mice models of MAFLD and MAFLD-induced HCC (MAFLD-HCC). We utilized 16S rRNA gene sequencing analysis to profile the composition of gut bacteria in fecal samples.<br />Results: Notably, we discovered that the absence of Plin5 alone is already associated with changes in gut microbiota composition. Moreover, feeding the mice a Western diet (WD) resulted in additional microbial alterations. Interestingly, Plin5 <superscript>-/-</superscript> animals exhibited an enrichment of the beneficial taxa Lactobacillus in both animal models.<br />Discussion: Our findings identify Plin5 as a major regulator of gut microbiota during the development of MAFLD and MAFLD-HCC.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.<br /> (Copyright © 2024 Krizanac, Štancl, Mass-Sanchez, Karlić, Moeckel, Lammers, Asimakopoulos and Weiskirchen.)

Details

Language :
English
ISSN :
2235-2988
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in cellular and infection microbiology
Publication Type :
Academic Journal
Accession number :
39469452
Full Text :
https://doi.org/10.3389/fcimb.2024.1443654